Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Primary sclerosing cholangitis is associated with a specific IBD phenotype

Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease, reports the latest issue of Inflammatory Bowel Diseases.

News image

Primary sclerosing cholangitis is strongly associated with inflammatory bowel disease.

Dr Kirsten Boonstra and colleagues from the Netherlands assessed the inflammatory bowel disease (IBD) phenotype associated with primary sclerosing cholangitis in a large well-phenotyped population-based

The team studied a primary sclerosing cholangitis cohort using endoscopic and histopathologic criteria.

Primary sclerosing cholangitis cases were identified and ascertained, fulfilling well-established criteria, in 39 hospitals in a geographically defined region of the Netherlands.

The research team recorded the inflammatory bowel disease location according to the Montreal Classification.

As this classification does not consider segmental inflammation, backwash ileitis, or rectal sparing, an additional subgroup analysis was performed in 80 cases and 80 age- and sex-matched inflammatory bowel disease controls.

The team reviewed all endoscopy and pathology reports filed between 2000 and 2010.

In all, 380 of a total of 579 primary sclerosing cholangitis patients had coexistent inflammatory bowel disease, mainly ulcerative colitis.

The team found that overall, 207 of the primary sclerosing cholangitis patients had a pancolitis, 32 a left-sided colitis, and 9 a proctitis only.

Left-sided colitis was seen in 16 ulcerative colitis controls
Inflammatory Bowel Diseases

The research team noted that 70 primary sclerosing cholangitis-Crohn's disease patients had an (ileo)colitis, and 4 had ileitis only.

In the subgroup analysis, the doctors identified 53 primary sclerosing cholangitis patients, 24  primary sclerosing cholangitis patients, and 3 primary sclerosing cholangitis-IBD patients.

The team found that 50 primary sclerosing cholangitis patients had a pancolitis, compared with 32 matched ulcerative colitis patients.

Left-sided colitis was seen in 16 ulcerative colitis controls, and in 1 primary sclerosing cholangitis patient.

Backwash ileitis and rectal sparing were rare findings in the cohorts under study.

Dr Boonstra's team conclued,  "Inflammatory bowel disease in primary sclerosing cholangitis patients represents a distinct phenotype in that pancolitis is observed in 94% of primary sclerosing cholangitis, and colitis in 96% of primary sclerosing cholangitis patients."

"Backwash ileitis and rectal sparing were rare findings in the primary sclerosing cholangitis patients."

Inflamm Bowel Dis 2012: 18,:12: 22702276


11 December 2012

Go to top of page Email this page Email this page to a colleague

 02 September 2015

Advanced search
 02 September 2015 
Anxiety and functional dyspepsia
 02 September 2015 
Cancer predisposition genes in suspected Lynch syndrome
 02 September 2015 
Adherence to a gluten-free diet in celiac disease
 01 September 2015 
Nonceliac wheat sensitivity and autoimmune disease
 01 September 2015 
Dysphagia after antireflux surgery
 01 September 2015 
Predict treatment success in ulcerative colitis
 31 August 2015 

Fecal microbiota transplantation in IBD

 31 August 2015 
Probiotics and liver transplantation
 31 August 2015 
Cancer incidence in Barrett's
 28 August 2015 
Statin use and survival in pancreatic cancer
 28 August 2015 
Bacterial endotoxin and NAFLD
 28 August 2015 
Interferon-free regimens for Hep C
 27 August 2015 
HCV in Egypt
 27 August 2015 
Gene expression for hepatocellular carcinoma
 27 August 2015 
Liver abnormalities in celiac disease
 26 August 2015 
Medical management of diverticular disease
 26 August 2015 
Treatment of erosive esophagitis
 26 August 2015 
Dermatological complications of anti-TNF therapy in IBD
 25 August 2015 
Markers for colorectal cancer screening
 25 August 2015 
Long-term PPI use and serum gastrin levels
 25 August 2015 
Treatment for HCV and HIV-1 co-infection
 24 August 2015 
Treatment for HCV and HIV-1 co-infection
 24 August 2015 
Cirrhosis in Hepatitis C patients
 24 August 2015 
Aspirin use and colorectal cancer survival
 21 August 2015 
Activity indexes in ulcerative colitis
 21 August 2015 
Coffee and gallstone disease
 21 August 2015 
Alcoholic cirrhosis in relapse after liver transplant
 20 August 2015 
Cirrhosis in the USA
 20 August 2015 
Mortality causes in liver cirrhosis
 20 August 2015 
Risk of death in IBD
 19 August 2015 
Predicting intestinal surgery in Crohn's disease
 19 August 2015 
Sleep positioning device reduces reflux
 19 August 2015 
Improved screening colonoscopy quality
 18 August 2015 
Health insurance influences HCV screening outcomes
 18 August 2015 
Somatostatin analogues in polycystic liver disease
 18 August 2015 
Global consensus report on H. pylori gastritis
 17 August 2015 
Biomarker of fibrosis stage in NAFLD
 17 August 2015 
Prognostic score for primary biliary cirrhosis
 17 August 2015 
Measuring subjective health in patients with IBS
 14 August 2015 
Factors that influence ulcerative colitis procedure type
 14 August 2015 
H. pylori in African American and Hispanic veterans
 14 August 2015 
Hep E virus in decompensated chronic liver disease
 13 August 2015 
H. pylori in drinking water
 13 August 2015 
Sofosbuvir-regimens in HCV
 13 August 2015 
IBS among Japanese adolescents
 12 August 2015 
Predictors of severity of IBD
 12 August 2015 
Infliximab in patients in IBD
 12 August 2015 
Peritoneal carcinomatosis in colorectal cancer
 11 August 2015 
Chemotherapy and intestinal microbiomes
 11 August 2015 
H. pylori and immune thrombocytopenic purpura
 11 August 2015 
Sexual dysfunction after rectal cancer treatment
 10 August 2015 
Predicting lymph node metastasis in T1 colorectal cancer
 10 August 2015 
Scoring systems to predict alcoholic hepatitis outcomes
 10 August 2015 
Sofosbuvir-based regimens in veterans with HCV
 07 August 2015 
Factors associated with changes in ulcerative colitis
 07 August 2015 
Bariatric surgery and NASH in obese patients
 07 August 2015 
Caffeine and fibrosis in Hep C
 06 August 2015 
Disparities in colonoscopic examination
 06 August 2015 
Weight loss and NASH
 06 August 2015 
Diagnosis of IBS

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us